Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A - PubMed (original) (raw)
Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A
F Pelloquin et al. In Vitro Cell Dev Biol. 1986 Dec.
Abstract
A simple method was devised for the establishment of continuous lymphoblastoid cell lines (LCL). Unfractionated mononuclear cells collected from healthy donors were infected in vitro by Epstein-Barr Virus (EBV) (strain B95-8) under specific conditions: an immunosuppressive drug, Cyclosporin-A (CS-A, Sandoz), associated with the use of a feeder layer (MRC-5) led to 100% efficiency of LCL establishment. A bank of 400 LCL was set up for completion of genetic studies. Regression and kinetics of virus-induced transformation were monitored and related to donors' EBV immune status. Mean time of LCL establishment and probability of regression among seropositive donors were not linked to any given value titer of antibodies against Viral Capsid Antigen (VCA) or against Epstein-Barr Nuclear Antigen (EBNA). However, when the anti-VCA:anti-EBNA ratio was considered, this parameter seemed to be linked to the kinetics of transformation but not to the probability of regression. Once LCL are established, large quantities of human cells can be produced. The complete cellular DNA is available so that any part of it can be scrutinized. Moreover, some of the phenotypic characteristics of these B cells can be used for a wide range of investigations.
Similar articles
- Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ. Hill AB, et al. J Exp Med. 1995 Jun 1;181(6):2221-8. doi: 10.1084/jem.181.6.2221. J Exp Med. 1995. PMID: 7539044 Free PMC article. - Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines.
Hui-Yuen J, McAllister S, Koganti S, Hill E, Bhaduri-McIntosh S. Hui-Yuen J, et al. J Vis Exp. 2011 Nov 8;(57):3321. doi: 10.3791/3321. J Vis Exp. 2011. PMID: 22090023 Free PMC article. - Establishment of spontaneously outgrowing lymphoblastoid cell lines with Cyclosporin A.
von Knebel Doeberitz M, Bornkamm GW, zur Hausen H. von Knebel Doeberitz M, et al. Med Microbiol Immunol. 1983;172(2):87-99. doi: 10.1007/BF02124509. Med Microbiol Immunol. 1983. PMID: 6310356 - Immortalizing genes of Epstein-Barr virus.
Middleton T, Gahn TA, Martin JM, Sugden B. Middleton T, et al. Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review. - Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
Tatsumi E. Tatsumi E. Hum Cell. 1992 Mar;5(1):79-86. Hum Cell. 1992. PMID: 1329932 Review.
Cited by
- Dexamethasone potentiates chimeric antigen receptor T cell persistence and function by enhancing IL-7Rα expression.
Munoz AM, Urak R, Taus E, Hsieh HJ, Awuah D, Vyas V, Lim L, Jin K, Lin SH, Priceman SJ, Clark MC, Goldberg L, Forman SJ, Wang X. Munoz AM, et al. Mol Ther. 2024 Feb 7;32(2):527-539. doi: 10.1016/j.ymthe.2023.12.017. Epub 2023 Dec 22. Mol Ther. 2024. PMID: 38140726 - The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma.
Worel N, Grabmeier-Pfistershammer K, Kratzer B, Schlager M, Tanzmann A, Rottal A, Körmöczi U, Porpaczy E, Staber PB, Skrabs C, Herkner H, Gudipati V, Huppa JB, Salzer B, Lehner M, Saxenhuber N, Friedberg E, Wohlfarth P, Hopfinger G, Rabitsch W, Simonitsch-Klupp I, Jäger U, Pickl WF. Worel N, et al. Front Immunol. 2023 Jan 9;13:1004703. doi: 10.3389/fimmu.2022.1004703. eCollection 2022. Front Immunol. 2023. PMID: 36700229 Free PMC article. - Large-scale manufacturing and characterization of CMV-CD19CAR T cells.
Wang X, Urak R, Walter M, Guan M, Han T, Vyas V, Chien SH, Gittins B, Clark MC, Mokhtari S, Cardoso A, Diamond DJ, Zaia J, Forman SJ, Nakamura R. Wang X, et al. J Immunother Cancer. 2022 Jan;10(1):e003461. doi: 10.1136/jitc-2021-003461. J Immunother Cancer. 2022. PMID: 35027426 Free PMC article. - Rationally Designed Transgene-Encoded Cell-Surface Polypeptide Tag for Multiplexed Programming of CAR T-cell Synthetic Outputs.
Johnson AJ, Wei J, Rosser JM, Künkele A, Chang CA, Reid AN, Jensen MC. Johnson AJ, et al. Cancer Immunol Res. 2021 Sep;9(9):1047-1060. doi: 10.1158/2326-6066.CIR-20-0470. Epub 2021 Jul 9. Cancer Immunol Res. 2021. PMID: 34244298 Free PMC article. - Cytomegalovirus-Specific T Cell Epitope Recognition in Congenital Cytomegalovirus Mother-Infant Pairs.
Materne EC, Lilleri D, Garofoli F, Lombardi G, Furione M, Zavattoni M, Gibson L. Materne EC, et al. Front Immunol. 2020 Nov 24;11:568217. doi: 10.3389/fimmu.2020.568217. eCollection 2020. Front Immunol. 2020. PMID: 33329532 Free PMC article.
References
- Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
- Biol Cell. 1984;50(3):295-8 - PubMed
- J Exp Med. 1977 Aug 1;146(2):495-508 - PubMed
- Int J Cancer. 1979 May 15;23(5):618-25 - PubMed
- Int J Cancer. 1973 May;11(3):499-520 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources